Skip to content

China

Novartis charts major expansion plan

Visitors use VR headsets to explore Novartis’ medical offerings at the eighth China International Import Expo in Shanghai in November. CHINA DAILY Swiss pharmaceutical company Novartis will expand its research and development, manufacturing capacity and operations footprint in China with a planned investment of more than 3.3 billion yuan ($460 million), the company said. The…

Enterprises play key role in innovation

As the integration of technological and industrial innovation is becoming central to China’s next stage of artificial intelligence development, enterprises are expected to play an even more essential role in driving breakthroughs, said industry experts and company executives during the Boao Forum for Asia Annual Conference 2026 in Hainan province. The comments came as China…

China approves innovative breast cancer therapy by Daiichi Sankyo, AstraZeneca

Daiichi Sankyo and AstraZeneca announce on Friday that their co-developed innovative medicine, Enhertu, has been approved for use in China as a neoadjuvant treatment for early-stage breast cancer. [Provided to chinadaily.com.cn] Japan’s Daiichi Sankyo and the United Kingdom’s AstraZeneca announced on Friday that their co-developed innovative medicine, Enhertu, has been approved for use in China…

Chinese smart tech brand rises to the top in robotic lawn mower market

Chinese smart technology brand MOVA has reached the top of global sales rankings in the fast-growing robotic lawn mower market, driven by advances in AI-powered perception and navigation technologies. MOVA, a maker of high-end smart equipment, ranked first worldwide in sales of LiDar-based robotic lawn mowers, according to an independent report by Frost & Sullivan.…

ANTA Sports sees revenue and profit rise to record high

ANTA Sports Products Limited reported on Wednesday record annual revenue and profit for 2025, reinforcing its position as the largest sportswear company in the country.  Revenue rose 13.3 percent from the previous year to 80.22 billion yuan ($11.63 billion), the company said. Operating profit increased 15 percent to 19.09 billion yuan, while operating margin edged…

Organon sees opportunities in China’s push for high-quality population development

Organon, a global healthcare company, said China’s efforts to improve population development and advance a more health-centered medical system are creating fresh opportunities for global healthcare companies on the sidelines of the China Development Forum 2026 in Beijing. The company said it sees strong potential in areas such as women’s health, fertility support and chronic…

US pharma company expands partnerships in China

As China accelerates the development of new quality productive forces and advances high-level opening-up, the country continues to create a favorable environment for innovation and international cooperation. In an exclusive interview with China Daily on the sidelines of the China Development Forum 2026, Jérôme Bouyer, senior vice-president of US pharmaceutical company AbbVie and president of…

MNCs leveraging China’s development trajectory

From left to right: Cui Jingyi, vice-president of Aveva and head of Aveva China; Zhang Ying, managing director of Dassault Systemes Greater China; Zhao Yongzhan, executive VP of Hitachi Energy, region head of Hitachi Energy Greater China; Camilla Dewoon, executive vice-president of Scania Group, head of Scania Group China Editor’s Note: As China launches its 15th Five-Year Plan (2026-30),…

MNC execs bullish on Beijing’s prospects

Executives of multinational corporations struck a bullish note late on Sunday at the China Development Forum 2026’s Beijing Night, expressing renewed confidence in investing in the Chinese capital following a keynote speech by Beijing’s top official. In his speech, Yin Li, Party secretary of Beijing, highlighted the city’s role as a global innovation hub, citing…

Xiaomi reports record 2025 revenue as EV business surpasses 100b yuan

Lei Jun, chairman CEO of Xiaomi, unveils its new-generation SU7 electric vehicle, in Beijing last week. [Photo provided to chinadaily.com.cn] Xiaomi Corp announced on Tuesday that it delivered its strongest annual performance to date in 2025, with total revenue reaching 457.3 billion yuan ($66.4 billion), a 25 percent year-on-year increase. Adjusted net profit rose 43.8…